|
1
|
Angelis A, Mellerio JE and Kanavos P:
Understanding the socioeconomic costs of dystrophic epidermolysis
bullosa in Europe: A costing and health-related quality of life
study. Orphanet J Rare Dis. 17(346)2022.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Fine JD: Epidemiology of inherited
epidermolysis bullosa based on incidence and prevalence estimates
from the national epidermolysis bullosa registry. JAMA Dermatology.
152:1231–1238. 2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Kho YC, Rhodes LM, Robertson SJ, Su J,
Varigos G, Robertson I, Hogan P, Orchard D and Murrell DF:
Epidemiology of epidermolysis bullosa in the antipodes: the
Australasian epidermolysis bullosa registry with a focus on herlitz
junctional epidermolysis bullosa. Arch Dermatol. 146:635–640.
2010.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Fine JD, Bruckner-Tuderman L, Eady RA,
Bauer EA, Bauer JW, Has C, Heagerty A, Hintner H, Hovnanian A,
Jonkman MF, et al: Inherited epidermolysis bullosa: updated
recommendations on diagnosis and classification. J Am Acad
Dermatol. 70:1103–1126. 2014.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Fine JD, Eady RA, Bauer EA, Bauer JW,
Bruckner-Tuderman L, Heagerty A, Hintner H, Hovnanian A, Jonkman
MF, Leigh I, et al: The classification of inherited epidermolysis
bullosa (EB): Report of the third international consensus meeting
on diagnosis and classification of EB. J Am Acad Dermatol.
58:931–950. 2008.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Varki R, Sadowski S, Pfendner E and Uitto
J: Epidermolysis bullosa. I. Molecular genetics of the junctional
and hemidesmosomal variants. J Med Genet. 43:641–652.
2006.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Kiritsi D, Kern JS, Schumann H, Kohlhase
J, Has C and Bruckner-Tuderman L: Molecular mechanisms of
phenotypic variability in junctional epidermolysis bullosa. J Med
Genet. 48:450–457. 2011.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Tampoia M, Abbracciavento L, Morrone M and
Fumarulo R: IL-6/IL-10 ratio as a prognostic and predictive marker
of the severity of inherited epidermolysis bullosa. Iran J Immunol.
14:340–349. 2017.PubMed/NCBI
|
|
9
|
Pfendner EG and Lucky AW: Dystrophic
epidermolysis bullosa. In: GeneReviews®. Adam MP,
Feldman J, Mirzaa GM, et al (eds). University of Washington,
Seattle, WA, 1993.
|
|
10
|
García M, Escamez MJ, Cuadrado-Corrales N,
Sánchez-Jimeno C, Illera N, López-Martínez MA, Trujillo-Tiebas MJ,
Ayuso C and Del Río M: Novel human pathological mutations. Gene
symbol: COL7A1. Disease: Epidermolysis bullosa dystrophica. Hum
Genet. 127:116–117. 2010.PubMed/NCBI
|
|
11
|
van den Akker PC, van Essen AJ, Kraak MM,
Meijer R, Nijenhuis M, Meijer G, Hofstra RM, Pas HH, Scheffer H and
Jonkman MF: Long-term follow-up of patients with recessive
dystrophic epidermolysis bullosa in the Netherlands: Expansion of
the mutation database and unusual phenotype-genotype correlations.
J Dermatol Sci. 56:9–18. 2009.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Fine JD and Mellerio JE: Extracutaneous
manifestations and complications of inherited epidermolysis
bullosa: Part I. Epithelial associated tissues. J Am Acad Dermatol.
61:367–384. 2009.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Mortell AE and Azizkhan RG: Epidermolysis
bullosa: Management of esophageal strictures and enteric access by
gastrostomy. Dermatol Clin. 28:311–318, x. 2010.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Colomb V, Bourdon-Lannoy E, Lambe C,
Sauvat F, Hadj Rabia S, Teillac D, De Prost Y and Bodemer C:
Nutritional outcome in children with severe generalized recessive
dystrophic epidermolysis bullosa: A short- and long-term evaluation
of gastrostomy and enteral feeding. Br J Dermatol. 166:354–361.
2012.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Hsu CK, Wang SP, Lee JY and McGrath JA:
Treatment of hereditary epidermolysis bullosa: Updates and future
prospects. Am J Clin Dermatol. 15:1–6. 2014.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Li M, Wei J, Xu G, Liu Y and Zhu J:
Surgery combined with molecular targeted therapy successfully
treated giant esophageal gastrointestinal stromal tumor. Oncologie.
24:349–356. 2022.
|
|
17
|
Zhan J, Wang W, Tang Y, Zhou N and Jiang
D: Development of a prognostic signature for esophageal cancer
based on a novel 7-DNA damage repair genes signature. Biocell.
46:2601–2613. 2022.
|
|
18
|
Nystrom A, Bruckner-Tuderman L and Kern
JS: Cell- and protein-based therapy approaches for epidermolysis
bullosa. Methods Mol Biol. 961:425–440. 2013.PubMed/NCBI View Article : Google Scholar
|
